Taking this into account, Colliers Securities initiated its Biomerica Inc [BMRA] rating to a Buy in a research note published on November 10, 2020; the price target was $13. A number of analysts have revised their coverage, including B. Riley FBR Inc.’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating.
Price Performance Review of BMRA
On Friday, Biomerica Inc [NASDAQ:BMRA] saw its stock fall -9.35% to $0.64. Over the last five days, the stock has gained 82.91%. Biomerica Inc shares have risen nearly 113.26% since the year began. Nevertheless, the stocks have fallen -33.02% over the past one year. While a 52-week high of $1.35 was reached on 01/16/25, a 52-week low of $0.24 was recorded on 01/03/25. SMA at 50 days reached $0.3446, while 200 days put it at $0.4338.
Levels Of Support And Resistance For BMRA Stock
The 24-hour chart illustrates a support level at 0.5780, which if violated will result in even more drops to 0.5160. On the upside, there is a resistance level at 0.7260. A further resistance level may holdings at 0.8120. The Relative Strength Index (RSI) on the 14-day chart is 73.49, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1861, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 63.64%. Stochastics %K at 45.55% indicates the stock is a holding.
How much short interest is there in Biomerica Inc?
A steep rise in short interest was recorded in Biomerica Inc stocks on 2024-12-31, dropping by -1.06 million shares to a total of 0.36 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 1.43 million shares. There was a decline of -291.61%, which implies that there is a negative sentiment for the stock.
